Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH notice says federal agencies are transitioning from “Artificial Intelligence” to “Super Intelligence,” and the displayed site revision advances from v3.7.1 to v3.7.2.
    Difference
    0.7%
    Check dated 2026-10-20T21:50:04.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T21:44:10.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A new Study Status section was added to the record history on 2026-09-22, and a new version entry dated 2026-09-21 (version 14) was created to reflect updated status. Additionally, the prior entry dated 2026-04-13 was removed from the history.
    Difference
    0.4%
    Check dated 2026-09-22T23:10:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The record history now includes a new revision labeled v3.7.0. The previous revision v3.6.6 has been removed, indicating a version update to the page rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T21:47:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision v3.6.6 was added to the study history, indicating an administrative update to the record; the update does not modify substantive details of the trial.
    Difference
    0.1%
    Check dated 2026-09-01T18:30:36.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry labeled 'Revision: v3.6.5' was added to the study record history, representing an update to the page content. The previous revision 'Revision: v3.6.4' was removed from the history.
    Difference
    0.1%
    Check dated 2026-08-11T18:22:21.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.